Sanvivo (YC W23)
With Sanvivo GmbH, we have set ourselves the goal of strengthening local pharmacies. Our focus is on our digital and technical expertise, which we make available to pharmacists in the most uncomplicated way possible. We act as a reliable and open partner who knows and understands the healthcare industry very well, connects pharmacies with each other and makes everyday life easier. As Sanvivo GmbH, we listen to the market and offer modern solutions and products with sub-brands for the current challenges facing pharmacies as well as consumer requirements and trends.
Sanvivo (YC W23) is a software development company headquartered in Weil, Bavaria, Germany. The team counts 9 people. Sanvivo (YC W23) has a website drawing 718 monthly visits and most of the team based in DEU.
Employee growth
Sanvivo (YC W23) grew from ~1 employees in November 2021 to 5 by April 2024, reaching 9 by September 2026, tracked weekly in Crustdata's proprietary dataset since November 2021.
Investors
Sanvivo (YC W23)'s 2 backers include leading firms such as Heal Capital and Y Combinator.
Leadership
Sanvivo (YC W23)'s leadership includes Co-Founder & Chief Technology Officer Sven Wildermann, Co-Founder & CEO Dr. Julius Rachor, Chief Pharmaceutical Officer Nikolai Alemi, and Co-Founder & COO Dominic Haul.
Industries & markets
Sanvivo (YC W23) is classified across the following industries, categories, and markets that Crustdata tracks for competitive analysis and sector benchmarking.
See the top Software Development companies ranked by size, growth and funding.
Sanvivo (YC W23) Growth Score
Sanvivo (YC W23) has a Crustdata Growth Score of 0 out of 100, which points to modest growth. Behind the number: headcount grew 0% year over year, web traffic fell 58% quarter over quarter, and it last raised funding 41 months ago.
Sanvivo (YC W23) FAQs
Below are 9 of the most common questions about Sanvivo (YC W23), answered with data tracked and refreshed weekly using Crustdata's proprietary dataset.